0001181431-13-054871.txt : 20131023 0001181431-13-054871.hdr.sgml : 20131023 20131023060122 ACCESSION NUMBER: 0001181431-13-054871 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131021 FILED AS OF DATE: 20131023 DATE AS OF CHANGE: 20131023 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sorrento Therapeutics, Inc. CENTRAL INDEX KEY: 0000850261 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 330344842 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6042 CORNERSTONE CT. WEST STREET 2: SUITE B CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-210-3700 MAIL ADDRESS: STREET 1: 6042 CORNERSTONE CT. WEST STREET 2: SUITE B CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: QUIKBYTE SOFTWARE INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Uy George CENTRAL INDEX KEY: 0001586890 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52228 FILM NUMBER: 131164617 MAIL ADDRESS: STREET 1: 435 PICCOLO CITY: IRVINE STATE: CA ZIP: 92620 4 1 rrd393289.xml FORM 4 X0306 4 2013-10-21 0 0000850261 Sorrento Therapeutics, Inc. SRNE 0001586890 Uy George C/O SORRENTO THERAPEUTICS, INC. 6042 CORNERSTONE CT. WEST, SUITE B SAN DIEGO CA 92121 0 1 0 0 Chief Commercial Officer Convertible Note 2013-10-21 4 A 0 0 35000 A 2017-04-15 Common Stock and/or Warrants 0 0 D George Uy purchased $35,000 principal amount of convertible notes on October 21, 2013 (the "Notes"). In the event that Sorrento Therapeutics, Inc. (the "Company") issues and sells shares of its equity securities to investors after the date of the Notes and on or before the maturity date in an equity financing with total proceeds to the Company of not less than $10,000,000, then the outstanding principal balance of the Notes shall automatically convert into such equity securities at a conversion price equal to the price per share paid by the investors purchasing the equity securities. In addition, at any time after November 30, 2013 and until the Notes are no longer outstanding, the principal amount under the Notes shall be convertible into shares of Common Stock at the option of the holder, at any time. (Continued in Footnote 2) The principal amount of the Notes shall be converted based upon the ten (10) trading day volume weighted average closing price of the Common Stock for the trading days immediately prior to the date of receipt of notice of voluntary conversion. /s/ George Uy 2013-10-23